Moreover, treatment of CRC cells with RSV suppressed their cross-talk with tumor microenvironment (TME) cells through activation of the Sirt1 pathway, thus abating cell survival and migration [103]. This evidence concerns the gene SIRT1 and colorectal carcinoma.